Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.6 Billion USD | 27.8% |
| 2022 | 7.33 Billion USD | -1.03% |
| 2021 | 7.4 Billion USD | 5.36% |
| 2020 | 7.02 Billion USD | 63.96% |
| 2019 | 4.28 Billion USD | -47.72% |
| 2018 | 8.2 Billion USD | -41.94% |
| 2017 | 14.12 Billion USD | -19.9% |
| 2016 | 17.63 Billion USD | -20.55% |
| 2015 | 22.19 Billion USD | 45.38% |
| 2014 | 15.26 Billion USD | 237.42% |
| 2013 | 4.52 Billion USD | 12.81% |
| 2012 | 4.01 Billion USD | 5.81% |
| 2011 | 3.78 Billion USD | -4.35% |
| 2010 | 3.96 Billion USD | 12.27% |
| 2009 | 3.52 Billion USD | 31.76% |
| 2008 | 2.67 Billion USD | 23.75% |
| 2007 | 2.16 Billion USD | 385.27% |
| 2006 | -758.75 Million USD | -168.29% |
| 2005 | 1.11 Billion USD | 75.89% |
| 2004 | 631.68 Million USD | 498.1% |
| 2003 | -158.67 Million USD | -295.88% |
| 2002 | 81 Million USD | 167.12% |
| 2001 | -120.68 Million USD | -130.68% |
| 2000 | -52.31 Million USD | -1.2% |
| 1999 | -51.7 Million USD | 30.42% |
| 1998 | -74.3 Million USD | -61.87% |
| 1997 | -45.9 Million USD | -27.15% |
| 1996 | -36.1 Million USD | -12.81% |
| 1995 | -32 Million USD | -8.47% |
| 1994 | -29.5 Million USD | 0.0% |
| 1992 | -18.2 Million USD | -188.89% |
| 1991 | -6.3 Million USD | -31.25% |
| 1990 | -4.8 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.3 Billion USD | -8.14% |
| 2024 Q2 | 2.68 Billion USD | 16.77% |
| 2023 Q4 | 2.5 Billion USD | -4.46% |
| 2023 Q1 | 1.7 Billion USD | -24.79% |
| 2023 FY | 9.36 Billion USD | 27.8% |
| 2023 Q2 | 1.66 Billion USD | -2.35% |
| 2023 Q3 | 2.62 Billion USD | 57.54% |
| 2022 Q3 | 2.83 Billion USD | 39.82% |
| 2022 Q2 | 2.02 Billion USD | 562.19% |
| 2022 FY | 7.33 Billion USD | -1.03% |
| 2022 Q4 | 2.26 Billion USD | -20.09% |
| 2022 Q1 | -439 Million USD | -146.7% |
| 2021 FY | 7.4 Billion USD | 5.36% |
| 2021 Q1 | 2.89 Billion USD | 9.02% |
| 2021 Q2 | 2.24 Billion USD | -22.28% |
| 2021 Q3 | 3.84 Billion USD | 71.06% |
| 2021 Q4 | 940 Million USD | -75.53% |
| 2020 Q1 | 2.4 Billion USD | 119.76% |
| 2020 Q2 | -2.98 Billion USD | -224.19% |
| 2020 Q4 | 2.65 Billion USD | 32.48% |
| 2020 FY | 7.02 Billion USD | 63.96% |
| 2020 Q3 | 2 Billion USD | 167.08% |
| 2019 Q4 | 1.09 Billion USD | 174.2% |
| 2019 Q1 | 2.23 Billion USD | 95.54% |
| 2019 FY | 4.28 Billion USD | -47.72% |
| 2019 Q3 | -1.47 Billion USD | -160.62% |
| 2019 Q2 | 2.43 Billion USD | 8.63% |
| 2018 Q4 | 1.14 Billion USD | -56.39% |
| 2018 FY | 8.2 Billion USD | -41.94% |
| 2018 Q3 | 2.62 Billion USD | 15.04% |
| 2018 Q2 | 2.28 Billion USD | 5.9% |
| 2018 Q1 | 2.15 Billion USD | -6.02% |
| 2017 Q4 | 2.29 Billion USD | -39.9% |
| 2017 Q1 | 3.76 Billion USD | -6.87% |
| 2017 FY | 14.12 Billion USD | -19.9% |
| 2017 Q2 | 4.25 Billion USD | 12.93% |
| 2017 Q3 | 3.81 Billion USD | -10.39% |
| 2016 Q2 | 4.53 Billion USD | -2.43% |
| 2016 FY | 17.63 Billion USD | -20.55% |
| 2016 Q1 | 4.65 Billion USD | -17.26% |
| 2016 Q3 | 4.39 Billion USD | -3.06% |
| 2016 Q4 | 4.04 Billion USD | -8.05% |
| 2015 Q4 | 5.62 Billion USD | 0.64% |
| 2015 Q3 | 5.58 Billion USD | -0.55% |
| 2015 Q2 | 5.61 Billion USD | 4.56% |
| 2015 Q1 | 5.37 Billion USD | 24.04% |
| 2015 FY | 22.19 Billion USD | 45.38% |
| 2014 FY | 15.26 Billion USD | 237.42% |
| 2014 Q4 | 4.33 Billion USD | 24.45% |
| 2014 Q3 | 3.47 Billion USD | -21.16% |
| 2014 Q1 | 3.04 Billion USD | 154.18% |
| 2014 Q2 | 4.41 Billion USD | 45.03% |
| 2013 Q3 | 1.14 Billion USD | -0.52% |
| 2013 FY | 4.52 Billion USD | 12.81% |
| 2013 Q1 | 1.02 Billion USD | -7.38% |
| 2013 Q2 | 1.15 Billion USD | 12.54% |
| 2013 Q4 | 1.19 Billion USD | 4.28% |
| 2012 FY | 4.01 Billion USD | 5.81% |
| 2012 Q4 | 1.1 Billion USD | 6.04% |
| 2012 Q3 | 1.04 Billion USD | -1.43% |
| 2012 Q2 | 1.05 Billion USD | 32.36% |
| 2012 Q1 | 800.18 Million USD | -7.76% |
| 2011 FY | 3.78 Billion USD | -4.35% |
| 2011 Q4 | 867.47 Million USD | -13.57% |
| 2011 Q3 | 1 Billion USD | -1.28% |
| 2011 Q2 | 1.01 Billion USD | 12.72% |
| 2011 Q1 | 901.96 Million USD | 8.75% |
| 2010 Q2 | 992.62 Million USD | -14.51% |
| 2010 Q3 | 979.07 Million USD | -1.37% |
| 2010 FY | 3.96 Billion USD | 12.27% |
| 2010 Q4 | 829.38 Million USD | -15.29% |
| 2010 Q1 | 1.16 Billion USD | 8.98% |
| 2009 FY | 3.52 Billion USD | 31.76% |
| 2009 Q2 | 761.06 Million USD | -5.85% |
| 2009 Q3 | 894.4 Million USD | 17.52% |
| 2009 Q4 | 1.06 Billion USD | 19.12% |
| 2009 Q1 | 808.31 Million USD | 13.66% |
| 2008 Q4 | 711.14 Million USD | 2.5% |
| 2008 Q3 | 693.83 Million USD | 14.59% |
| 2008 Q2 | 605.51 Million USD | -9.36% |
| 2008 Q1 | 668.04 Million USD | 29.85% |
| 2008 FY | 2.67 Billion USD | 23.75% |
| 2007 Q3 | 547.03 Million USD | 0.77% |
| 2007 Q4 | 514.48 Million USD | -5.95% |
| 2007 Q2 | 542.84 Million USD | -3.09% |
| 2007 Q1 | 560.14 Million USD | 136.06% |
| 2007 FY | 2.16 Billion USD | 385.27% |
| 2006 FY | -758.75 Million USD | -168.29% |
| 2006 Q2 | 365.31 Million USD | -1.71% |
| 2006 Q1 | 371.65 Million USD | 2.66% |
| 2006 Q3 | 57.54 Million USD | -84.25% |
| 2006 Q4 | -1.55 Billion USD | -2799.44% |
| 2005 Q1 | 222.43 Million USD | 34.56% |
| 2005 FY | 1.11 Billion USD | 75.89% |
| 2005 Q4 | 362.02 Million USD | 44.88% |
| 2005 Q3 | 249.88 Million USD | -9.71% |
| 2005 Q2 | 276.75 Million USD | 24.42% |
| 2004 Q1 | 144.42 Million USD | 64.16% |
| 2004 Q3 | 163.77 Million USD | 3.52% |
| 2004 Q4 | 165.29 Million USD | 0.93% |
| 2004 Q2 | 158.19 Million USD | 9.54% |
| 2004 FY | 631.68 Million USD | 498.1% |
| 2003 Q1 | -433.59 Million USD | -1420.37% |
| 2003 Q4 | 87.97 Million USD | 11.12% |
| 2003 Q2 | 107.77 Million USD | 124.86% |
| 2003 Q3 | 79.17 Million USD | -26.54% |
| 2003 FY | -158.67 Million USD | -295.88% |
| 2002 Q4 | 32.83 Million USD | -8.57% |
| 2002 FY | 81 Million USD | 167.12% |
| 2002 Q2 | 19.19 Million USD | 376.45% |
| 2002 Q3 | 35.91 Million USD | 87.13% |
| 2002 Q1 | -6.94 Million USD | 72.14% |
| 2001 Q1 | -25.8 Million USD | -38.34% |
| 2001 Q3 | -360.86 Million USD | -964.66% |
| 2001 Q2 | -33.89 Million USD | -31.37% |
| 2001 FY | -120.68 Million USD | -130.68% |
| 2001 Q4 | -24.92 Million USD | 93.09% |
| 2000 Q1 | -6.94 Million USD | 29.17% |
| 2000 FY | -52.31 Million USD | -1.2% |
| 2000 Q2 | -5.78 Million USD | 16.65% |
| 2000 Q3 | -20.94 Million USD | -261.99% |
| 2000 Q4 | -18.65 Million USD | 10.94% |
| 1999 Q2 | -17.5 Million USD | 9.79% |
| 1999 Q3 | -16.2 Million USD | 7.43% |
| 1999 Q4 | -9.8 Million USD | 39.51% |
| 1999 FY | -51.7 Million USD | 30.42% |
| 1999 Q1 | -19.4 Million USD | 4.43% |
| 1998 Q3 | -21.7 Million USD | -9.6% |
| 1998 Q1 | -12.2 Million USD | 29.89% |
| 1998 Q2 | -19.8 Million USD | -62.3% |
| 1998 Q4 | -20.3 Million USD | 6.45% |
| 1998 FY | -74.3 Million USD | -61.87% |
| 1997 Q4 | -17.4 Million USD | -15.23% |
| 1997 Q2 | -1.4 Million USD | 88.24% |
| 1997 Q1 | -11.9 Million USD | 3.25% |
| 1997 FY | -45.9 Million USD | -27.15% |
| 1997 Q3 | -15.1 Million USD | -978.57% |
| 1996 Q3 | 5.5 Million USD | 134.59% |
| 1996 FY | -36.1 Million USD | -12.81% |
| 1996 Q4 | -12.3 Million USD | -323.64% |
| 1996 Q2 | -15.9 Million USD | -19.55% |
| 1996 Q1 | -13.3 Million USD | 0.0% |
| 1995 Q2 | -9 Million USD | 10.0% |
| 1995 Q3 | -9.9 Million USD | -10.0% |
| 1995 FY | -32 Million USD | -8.47% |
| 1995 Q1 | -10 Million USD | -8.7% |
| 1994 Q3 | -7.9 Million USD | 2.47% |
| 1994 Q4 | -9.2 Million USD | -16.46% |
| 1994 FY | -29.5 Million USD | 0.0% |
| 1994 Q1 | -9.1 Million USD | -19.74% |
| 1994 Q2 | -8.1 Million USD | 10.99% |
| 1993 Q4 | -7.6 Million USD | -11.76% |
| 1993 Q1 | -6.9 Million USD | -43.75% |
| 1993 Q2 | -5.8 Million USD | 15.94% |
| 1993 Q3 | -6.8 Million USD | -17.24% |
| 1992 FY | -18.2 Million USD | -188.89% |
| 1992 Q4 | -4.8 Million USD | -29.73% |
| 1992 Q3 | -3.7 Million USD | -32.14% |
| 1992 Q2 | -2.8 Million USD | 61.11% |
| 1992 Q1 | -7.2 Million USD | -1540.0% |
| 1991 Q1 | -4.9 Million USD | -5000.0% |
| 1991 Q2 | 200 Thousand USD | 104.08% |
| 1991 Q3 | 200 Thousand USD | 0.0% |
| 1991 Q4 | 500 Thousand USD | 150.0% |
| 1991 FY | -6.3 Million USD | -31.25% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q2 | 100 Thousand USD | 0.0% |
| 1990 Q4 | 100 Thousand USD | 0.0% |
| 1990 FY | -4.8 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Amgen Inc. | 7.89 Billion USD | 3.698% |
| AstraZeneca PLC | 8.19 Billion USD | 7.177% |
| Biogen Inc. | 1.29 Billion USD | -486.444% |
| MIRA Pharmaceuticals, Inc. | -8.52 Million USD | 89297.225% |
| Scilex Holding Company | -105.43 Million USD | 7313.248% |
| Scilex Holding Company | -105.43 Million USD | 7313.248% |